These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 27747610)
21. Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9-year retrospective study. Shemer A; Kivity S; Shoenfeld Y Transfusion; 2018 Feb; 58(2):430-438. PubMed ID: 29193136 [TBL] [Abstract][Full Text] [Related]
22. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related]
23. Treatment of immune thrombocytopenic purpura in children : current concepts. Shad AT; Gonzalez CE; Sandler SG Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997 [TBL] [Abstract][Full Text] [Related]
24. The effect of ABO and Rh blood type on the response to intravenous immune globulin (IVIG) in children with immune thrombocytopenic purpura (ITP). Sturgill MG; Nagabandi SR; Drachtman RA; Ettinger AG; Rubin J; Ettinger LJ J Pediatr Hematol Oncol; 1997; 19(6):523-5. PubMed ID: 9407938 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS. Majluf-Cruz A; Luna-Castaños G; Huitrón S; Nieto-Cisneros L Am J Hematol; 1998 Oct; 59(2):127-32. PubMed ID: 9766797 [TBL] [Abstract][Full Text] [Related]
26. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [TBL] [Abstract][Full Text] [Related]
27. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Blanchette V; Carcao M Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140 [TBL] [Abstract][Full Text] [Related]
28. Intravenous immune globulin use in Canada. Hanna K; Poulin-Costello M; Preston M; Maresky N Can J Clin Pharmacol; 2003; 10(1):11-6. PubMed ID: 12687032 [TBL] [Abstract][Full Text] [Related]
29. Small molecule phagocytosis inhibitors for immune cytopenias. Neschadim A; Kotra LP; Branch DR Autoimmun Rev; 2016 Aug; 15(8):843-7. PubMed ID: 27296447 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the impact and burden of illness of adult chronic ITP in the US. Saleh MN; Fisher M; Grotzinger KM Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465 [TBL] [Abstract][Full Text] [Related]
31. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim. Deuson R; Danese M; Mathias SD; Schoonen M; Fryzek J J Med Econ; 2012; 15(5):956-76. PubMed ID: 22533524 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature. Harmon M; Riazi K; Callum J; Arnold DM; Barty R; Sidhu D; Heddle NM; MacLeod L; Li N Allergy Asthma Clin Immunol; 2023 Sep; 19(1):85. PubMed ID: 37717038 [TBL] [Abstract][Full Text] [Related]
34. An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia. Sholapur NS; Hamilton K; Butler L; Heddle NM; Arnold DM Transfusion; 2016 Jul; 56(7):1739-44. PubMed ID: 27145296 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia. Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375 [TBL] [Abstract][Full Text] [Related]
36. Effect of intravenous immunoglobulin on inhibition of fibrinogen binding to platelets by sera from patients with immune thrombocytopenia. Kamiyama M; Yoshimura Y; Chen K; Arkel YS Am J Hematol; 1993 Oct; 44(2):77-84. PubMed ID: 8266923 [TBL] [Abstract][Full Text] [Related]
37. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Blanchette VS; Kirby MA; Turner C Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297 [TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group. Constantine MM; Thomas W; Whitman L; Kahwash E; Dolan S; Smith S; Caudle CJ; Burton E; Anderson DR; Transfusion; 2007 Nov; 47(11):2072-80. PubMed ID: 17958537 [TBL] [Abstract][Full Text] [Related]